Free Trial

F5 (FFIV) Financials

F5 logo
$286.59 +4.49 (+1.59%)
Closing price 05/27/2025 04:00 PM Eastern
Extended Trading
$286.50 -0.09 (-0.03%)
As of 05/27/2025 05:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Annual Income Statements for F5

Annual Income Statements for F5

This table shows F5's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 9/30/2024 9/30/2023 9/30/2022 9/30/2021 9/30/2020 9/30/2019 9/30/2018 9/30/2017 9/30/2016 9/30/2015
Net Income / (Loss) Attributable to Common Shareholders
567 395 322 331 307 428 454 421 366 365
Consolidated Net Income / (Loss)
567 395 322 331 307 428 454 421 366 365
Net Income / (Loss) Continuing Operations
567 395 322 331 307 428 454 421 366 365
Total Pre-Tax Income
695 486 385 387 396 541 604 576 550 561
Total Operating Income
659 473 404 394 392 518 591 564 547 553
Total Gross Profit
2,258 2,220 2,156 2,110 1,943 1,886 1,800 1,737 1,658 1,588
Total Revenue
2,816 2,813 2,696 2,603 2,351 2,242 2,161 2,090 1,995 1,920
Operating Revenue
2,816 2,813 2,696 2,603 2,351 2,242 2,161 2,090 1,995 1,920
Total Cost of Revenue
558 593 540 493 408 357 361 353 337 332
Operating Cost of Revenue
558 593 540 493 408 357 361 353 337 332
Total Operating Expenses
1,600 1,747 1,752 1,716 1,551 1,367 1,209 1,173 1,110 1,035
Selling, General & Admin Expense
269 263 275 274 258 211 160 157 138 136
Marketing Expense
832 878 927 930 843 749 664 652 629 603
Research & Development Expense
490 540 543 513 441 408 366 350 334 297
Restructuring Charge
8.66 65 7.91 0.00 7.80 0.00 18 13 0.00 0.00
Total Other Income / (Expense), net
37 13 -18 -7.09 4.13 23 13 12 2.51 8.45
Other Income / (Expense), net
37 13 -18 -7.09 4.13 23 13 12 2.51 8.45
Income Tax Expense
129 91 63 56 89 113 150 155 184 196
Basic Earnings per Share
$9.65 $6.59 $5.34 $5.46 $5.05 $7.12 $7.41 $6.56 $5.43 $5.07
Weighted Average Basic Shares Outstanding
58.72M 59.91M 60.27M 60.71M 60.91M 60.04M 61.26M 64.17M 67.43M 71.94M
Diluted Earnings per Share
$9.55 $6.55 $5.27 $5.34 $5.01 $7.08 $7.32 $6.50 $5.38 $5.03
Weighted Average Diluted Shares Outstanding
59.36M 60.27M 61.10M 62.06M 61.38M 60.46M 62.01M 64.78M 67.98M 72.55M
Weighted Average Basic & Diluted Shares Outstanding
58.61M 59.71M 60.37M 61.23M 61.60M 60.10M 61.20M 64.10M 67.40M 72M

Quarterly Income Statements for F5

This table shows F5's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Net Income / (Loss) Attributable to Common Shareholders
146 166 165 144 119 138 152 89 81 72 89
Consolidated Net Income / (Loss)
146 166 165 144 119 138 152 89 81 72 89
Net Income / (Loss) Continuing Operations
146 166 165 144 119 138 152 89 81 72 89
Total Pre-Tax Income
171 209 204 172 146 174 175 106 109 96 100
Total Operating Income
159 205 191 163 140 165 172 104 106 91 108
Total Gross Profit
590 626 603 559 540 556 566 561 548 545 553
Total Revenue
731 766 747 695 681 693 707 703 703 700 700
Operating Revenue
731 766 747 695 681 693 707 703 703 700 700
Total Cost of Revenue
141 141 144 136 141 136 141 142 156 155 147
Operating Cost of Revenue
141 141 144 136 141 136 141 142 156 155 147
Total Operating Expenses
431 421 412 396 400 392 394 457 441 454 445
Selling, General & Admin Expense
77 73 71 66 67 65 62 65 67 70 70
Marketing Expense
218 206 217 206 211 199 205 207 233 233 237
Research & Development Expense
137 131 124 124 122 120 128 129 141 142 139
Restructuring Charge
0.00 11 - 0.09 0.09 8.47 - 57 0.00 8.74 -
Total Other Income / (Expense), net
12 3.96 12 8.53 5.97 9.88 3.09 2.90 2.74 4.70 -7.81
Other Income / (Expense), net
12 3.96 12 8.53 5.97 9.88 3.09 2.90 2.74 4.70 -7.81
Income Tax Expense
26 43 38 28 27 36 23 17 27 24 10
Basic Earnings per Share
$2.51 $2.85 $2.83 $2.46 $2.02 $2.34 $2.56 $1.48 $1.35 $1.20 $1.49
Weighted Average Basic Shares Outstanding
57.89M 58.31M 58.72M 58.58M 58.79M 59.12M 59.91M 59.98M 60.33M 60.10M 60.27M
Diluted Earnings per Share
$2.48 $2.82 $2.79 $2.44 $2.00 $2.32 $2.53 $1.48 $1.34 $1.20 $1.47
Weighted Average Diluted Shares Outstanding
58.76M 59.06M 59.36M 59.15M 59.58M 59.65M 60.27M 60.31M 60.69M 60.39M 61.10M
Weighted Average Basic & Diluted Shares Outstanding
57.43M 57.65M 58.61M 58.28M 58.61M 58.81M 59.71M 59.31M 60.47M 60.12M 60.37M

Annual Cash Flow Statements for F5

This table details how cash moves in and out of F5's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 9/30/2024 9/30/2023 9/30/2022 9/30/2021 9/30/2020 9/30/2019 9/30/2018 9/30/2017 9/30/2016 9/30/2015
Net Change in Cash & Equivalents
276 37 184 -268 251 178 -246 162 122 117
Net Cash From Operating Activities
792 653 443 645 661 748 761 740 712 685
Net Cash From Continuing Operating Activities
792 653 443 645 661 748 761 740 712 685
Net Income / (Loss) Continuing Operations
567 395 322 331 307 428 454 421 366 365
Consolidated Net Income / (Loss)
567 395 322 331 307 428 454 421 366 365
Depreciation Expense
107 113 116 115 96 69 59 61 57 53
Non-Cash Adjustments To Reconcile Net Income
251 280 295 323 253 179 159 175 159 147
Changes in Operating Assets and Liabilities, net
-133 -134 -291 -125 4.72 73 89 83 130 120
Net Cash From Investing Activities
-59 36 218 -445 -747 -415 -456 -32 63 -11
Net Cash From Continuing Investing Activities
-59 36 218 -445 -747 -415 -456 -32 63 -11
Purchase of Property, Plant & Equipment
-30 -54 -34 -31 -60 -104 -53 -39 -63 -60
Acquisitions
-33 -35 -68 -411 -956 -612 0.00 -4.00 -4.75 -6.78
Purchase of Investments
-2.10 -1.79 -61 -472 -584 -603 -855 -447 -355 -610
Sale and/or Maturity of Investments
6.24 127 381 469 853 903 452 457 486 667
Net Cash From Financing Activities
-457 -653 -477 -468 337 -155 -551 -546 -653 -557
Net Cash From Continuing Financing Activities
-457 -653 -477 -468 337 -155 -551 -546 -653 -557
Repayment of Debt
0.00 -350 -20 -20 -13 0.00 0.00 - - -
Repurchase of Common Equity
-501 -350 -500 -500 -100 -201 -600 -600 -700 -607
Issuance of Common Equity
55 60 65 66 53 46 49 47 45 40
Other Financing Activities, net
-12 -13 -21 -14 -2.54 0.00 0.00 7.02 2.61 9.52
Cash Interest Paid
0.00 2.97 7.98 5.28 6.57 0.00 0.00 - - -
Cash Income Taxes Paid
182 192 110 99 80 101 105 163 164 189

Quarterly Cash Flow Statements for F5

This table details how cash moves in and out of F5's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Net Change in Cash & Equivalents
106 78 139 34 81 23 121 -58 129 -155 219
Net Cash From Operating Activities
257 203 247 159 222 165 190 165 141 158 154
Net Cash From Continuing Operating Activities
257 203 247 159 222 165 190 165 141 158 154
Net Income / (Loss) Continuing Operations
146 166 165 144 119 138 152 89 81 72 89
Consolidated Net Income / (Loss)
146 166 165 144 119 138 152 89 81 72 89
Depreciation Expense
22 23 23 27 28 29 30 28 27 27 27
Non-Cash Adjustments To Reconcile Net Income
59 57 64 84 48 55 61 70 76 73 70
Changes in Operating Assets and Liabilities, net
29 -44 -5.84 -96 27 -58 -53 -22 -43 -16 -32
Net Cash From Investing Activities
-21 -9.97 -5.74 -6.45 -40 -7.14 -7.57 -8.41 -9.53 62 71
Net Cash From Continuing Investing Activities
-21 -9.97 -5.74 -6.45 -40 -7.14 -7.57 -8.41 -9.53 62 71
Purchase of Property, Plant & Equipment
-11 -8.07 -6.06 -5.85 -9.46 -9.05 -15 -15 -11 -13 -8.51
Net Cash From Financing Activities
-130 -115 -102 -119 -101 -135 -61 -215 -2.51 -375 -6.26
Net Cash From Continuing Financing Activities
-130 -115 -102 -119 -101 -135 -61 -215 -2.51 -375 -6.26
Repurchase of Common Equity
-127 -125 -101 -150 -100 -150 -60 -250 - -40 -
Issuance of Common Equity
0.18 24 0.21 32 0.68 22 0.46 37 0.28 22 0.86
Other Financing Activities, net
-2.72 -13 -1.57 -1.29 -1.84 -6.83 -1.84 -1.54 -2.79 -7.04 -2.12

Annual Balance Sheets for F5

This table presents F5's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 9/30/2024 9/30/2023 9/30/2022 9/30/2021 9/30/2020 9/30/2019 9/30/2018 9/30/2017 9/30/2016 9/30/2015
Total Assets
5,613 5,248 5,276 4,997 4,678 3,390 2,605 2,476 2,306 2,312
Total Current Assets
2,109 1,849 1,912 1,611 1,793 1,512 1,418 1,406 1,289 1,188
Cash & Equivalents
1,075 797 758 581 850 599 425 673 515 390
Accounts Receivable
389 455 470 341 296 322 295 292 268 279
Inventories, net
76 36 68 22 28 34 31 30 34 34
Other Current Assets
569 555 489 338 260 183 52 68 53 51
Plant, Property, & Equipment, net
151 170 168 191 229 223 145 122 123 96
Total Noncurrent Assets
3,353 3,229 3,196 3,195 2,655 1,655 1,043 948 894 1,028
Long-Term Investments
8.58 5.07 9.54 133 103 358 411 285 276 398
Goodwill
2,312 2,289 2,259 2,217 1,859 1,065 556 556 556 556
Noncurrent Deferred & Refundable Income Taxes
366 295 183 128 45 28 33 53 2.04 6.49
Other Noncurrent Operating Assets
666 640 744 717 648 204 42 54 60 68
Total Liabilities & Shareholders' Equity
5,613 5,248 5,276 4,997 4,678 3,390 2,605 2,476 2,306 2,312
Total Liabilities
2,484 2,448 2,807 2,637 2,446 1,629 1,320 1,247 1,121 996
Total Current Liabilities
1,490 1,473 1,840 1,392 1,288 1,106 954 935 844 755
Accounts Payable
68 63 113 62 64 63 58 51 34 51
Accrued Expenses
300 283 310 341 321 236 181 187 178 130
Current Deferred Revenue
1,122 - 1,067 - 883 807 716 696 632 574
Total Noncurrent Liabilities
994 975 967 1,246 1,157 523 366 313 277 240
Noncurrent Deferred Revenue
676 649 624 521 389 391 300 268 238 209
Noncurrent Deferred & Payable Income Tax Liabilities
7.18 4.64 2.78 2.41 0.60 0.31 0.04 0.06 4.21 0.90
Other Noncurrent Operating Liabilities
311 322 340 372 398 132 66 45 34 30
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
3,129 2,800 2,469 2,360 2,232 1,761 1,285 1,229 1,185 1,317
Total Preferred & Common Equity
3,129 2,800 2,469 2,360 2,232 1,761 1,285 1,229 1,185 1,317
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
3,129 2,800 2,469 2,360 2,232 1,761 1,285 1,229 1,185 1,317
Common Stock
5.89 24 91 192 305 143 20 18 13 10
Retained Earnings
3,144 2,799 2,404 2,188 1,946 1,638 1,287 1,230 1,185 1,322
Accumulated Other Comprehensive Income / (Loss)
-21 -23 -26 -20 -19 -19 -22 -18 -13 -15

Quarterly Balance Sheets for F5

This table presents F5's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Total Assets
5,907 5,901 5,613 5,414 5,385 5,349 5,248 5,119 5,223 5,086 5,276
Total Current Assets
2,336 2,342 2,109 1,986 1,952 1,962 1,849 1,714 1,825 1,715 1,912
Cash & Equivalents
1,259 1,151 1,075 935 903 823 797 677 735 606 758
Accounts Receivable
380 485 389 420 388 513 455 440 486 485 470
Inventories, net
68 73 76 79 70 36 36 46 51 59 68
Other Current Assets
629 633 569 552 590 587 555 538 534 510 489
Plant, Property, & Equipment, net
149 150 151 154 162 167 170 171 170 168 168
Total Noncurrent Assets
3,422 3,409 3,353 3,274 3,272 3,220 3,229 3,234 3,228 3,203 3,196
Long-Term Investments
13 11 8.58 7.30 6.34 6.17 5.07 5.89 4.74 7.81 9.54
Goodwill
2,320 2,312 2,312 2,312 2,312 2,289 2,289 2,289 2,289 2,259 2,259
Noncurrent Deferred & Refundable Income Taxes
407 378 366 344 325 307 295 271 235 209 183
Other Noncurrent Operating Assets
683 707 666 611 628 618 640 668 700 728 744
Total Liabilities & Shareholders' Equity
5,907 5,901 5,613 5,414 5,385 5,349 5,248 5,119 5,223 5,086 5,276
Total Liabilities
2,593 2,665 2,484 2,404 2,451 2,488 2,448 2,462 2,498 2,503 2,807
Total Current Liabilities
1,524 1,588 1,490 1,456 1,502 1,524 1,473 1,490 1,526 1,533 1,840
Accounts Payable
44 54 68 54 58 60 63 65 70 72 113
Accrued Expenses
280 316 300 260 267 279 283 274 296 331 310
Current Deferred Revenue
1,201 1,218 1,122 1,142 1,178 1,185 - 1,150 1,160 1,131 1,067
Total Noncurrent Liabilities
1,068 1,077 994 948 949 963 975 972 972 970 967
Noncurrent Deferred Revenue
722 729 676 630 634 645 649 642 636 629 624
Noncurrent Deferred & Payable Income Tax Liabilities
8.25 7.70 7.18 6.15 5.69 5.21 4.64 3.88 3.40 2.97 2.78
Other Noncurrent Operating Liabilities
338 341 311 311 309 314 322 327 332 338 340
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
3,314 3,236 3,129 3,011 2,933 2,861 2,800 2,658 2,726 2,582 2,469
Total Preferred & Common Equity
3,314 3,236 3,129 3,011 2,933 2,861 2,800 2,658 2,726 2,582 2,469
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
3,314 3,236 3,129 3,011 2,933 2,861 2,800 2,658 2,726 2,582 2,469
Common Stock
40 9.46 5.89 18 19 18 24 33 191 129 91
Retained Earnings
3,296 3,250 3,144 3,015 2,935 2,863 2,799 2,647 2,558 2,477 2,404
Accumulated Other Comprehensive Income / (Loss)
-22 -24 -21 -22 -21 -21 -23 -22 -23 -23 -26

Annual Metrics And Ratios for F5

This table displays calculated financial ratios and metrics derived from F5's official financial filings.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 9/30/2024 9/30/2023 9/30/2022 9/30/2021 9/30/2020 9/30/2019 9/30/2018 9/30/2017 9/30/2016 9/30/2015
Growth Metrics
- - - - - - - - - -
Revenue Growth
0.10% 4.35% 3.55% 10.74% 4.83% 3.75% 3.41% 4.76% 3.92% 10.84%
EBITDA Growth
34.04% 19.50% -0.27% 2.05% -19.25% -8.09% 4.18% 4.94% -1.18% 12.97%
EBIT Growth
43.10% 26.10% -0.40% -2.39% -26.74% -10.38% 4.91% 4.66% -2.04% 12.87%
NOPAT Growth
39.76% 13.78% 0.07% 10.87% -25.77% -7.70% 7.69% 13.21% 1.30% 16.42%
Net Income Growth
43.51% 22.59% -2.74% 7.74% -28.12% -5.72% 7.83% 15.01% 0.23% 17.30%
EPS Growth
45.80% 24.29% -1.31% 6.59% -29.24% -3.28% 12.62% 20.82% 6.96% 22.98%
Operating Cash Flow Growth
21.27% 47.62% -31.40% -2.38% -11.63% -1.74% 2.81% 4.04% 3.94% 24.69%
Free Cash Flow Firm Growth
52.24% 220.77% 342.07% 92.88% -207.77% -134.67% 5.02% 5.95% 5.84% 35.90%
Invested Capital Growth
2.73% 3.49% 14.16% 28.91% 203.56% 360.93% -128.24% -373.06% -81.70% -39.95%
Revenue Q/Q Growth
1.43% 0.25% 0.67% 2.65% 1.05% 1.25% 1.16% 0.61% 1.22% 1.91%
EBITDA Q/Q Growth
2.83% 14.85% -5.12% 6.33% -3.13% -5.39% 0.80% -1.24% 2.46% 0.16%
EBIT Q/Q Growth
4.30% 18.28% -5.81% 7.20% -4.94% -7.07% 0.90% -1.55% 2.50% -0.06%
NOPAT Q/Q Growth
1.12% 16.33% -4.87% 11.48% -4.30% -8.08% -0.72% 5.89% 3.68% 0.92%
Net Income Q/Q Growth
2.38% 18.90% -6.22% 11.09% -5.29% -8.17% -0.63% 6.80% 3.36% 0.83%
EPS Q/Q Growth
2.80% 19.31% -5.39% 10.79% -5.83% -7.69% 0.55% 8.15% 5.28% 1.82%
Operating Cash Flow Q/Q Growth
7.71% 5.74% -8.80% 3.39% -4.37% 0.24% -1.14% 1.23% 3.00% 2.01%
Free Cash Flow Firm Q/Q Growth
13.77% 9.54% -28.21% 31.74% -4.71% -4.68% -2.57% 2.96% 5.77% -2.88%
Invested Capital Q/Q Growth
-1.05% 1.57% 0.24% -1.00% -2.45% -9.43% -11.60% -63.56% -57.86% -13.71%
Profitability Metrics
- - - - - - - - - -
Gross Margin
80.20% 78.91% 79.98% 81.06% 82.65% 84.10% 83.28% 83.09% 83.10% 82.69%
EBITDA Margin
28.50% 21.28% 18.58% 19.30% 20.94% 27.19% 30.69% 30.46% 30.41% 31.98%
Operating Margin
23.39% 16.80% 14.98% 15.13% 16.69% 23.12% 27.34% 26.98% 27.44% 28.80%
EBIT Margin
24.70% 17.28% 14.30% 14.86% 16.86% 24.13% 27.93% 27.54% 27.56% 29.24%
Profit (Net Income) Margin
20.13% 14.04% 11.95% 12.72% 13.08% 19.07% 20.99% 20.13% 18.34% 19.01%
Tax Burden Percent
81.50% 81.27% 83.59% 85.61% 77.56% 79.05% 75.14% 73.11% 66.53% 65.03%
Interest Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate
18.50% 18.73% 16.41% 14.39% 22.44% 20.95% 24.86% 26.89% 33.47% 34.98%
Return on Invested Capital (ROIC)
26.58% 19.61% 18.70% 22.54% 35.00% 308.48% 0.00% 0.00% 425.39% 186.40%
ROIC Less NNEP Spread (ROIC-NNEP)
23.41% 18.00% 21.22% 23.29% 34.71% 307.19% 0.00% 0.00% 425.25% 185.93%
Return on Net Nonoperating Assets (RNNOA)
-7.47% -4.62% -5.36% -8.11% -19.60% -280.41% 0.00% 0.00% -396.15% -159.23%
Return on Equity (ROE)
19.12% 14.99% 13.34% 14.43% 15.40% 28.08% 36.08% 34.85% 29.25% 27.18%
Cash Return on Invested Capital (CROIC)
23.89% 16.18% 5.47% -2.73% -65.88% -43.19% 0.00% 0.00% 563.50% 236.33%
Operating Return on Assets (OROA)
12.81% 9.24% 7.50% 8.00% 9.83% 18.05% 23.76% 24.07% 23.81% 24.96%
Return on Assets (ROA)
10.44% 7.51% 6.27% 6.85% 7.62% 14.27% 17.85% 17.59% 15.84% 16.23%
Return on Common Equity (ROCE)
19.12% 14.99% 13.34% 14.43% 15.40% 28.08% 36.08% 34.85% 29.25% 27.18%
Return on Equity Simple (ROE_SIMPLE)
18.11% 14.10% 13.05% 14.03% 13.77% 24.28% 35.29% 34.23% 30.87% 27.72%
Net Operating Profit after Tax (NOPAT)
537 384 338 337 304 410 444 412 364 360
NOPAT Margin
19.06% 13.65% 12.52% 12.96% 12.94% 18.28% 20.54% 19.73% 18.25% 18.73%
Net Nonoperating Expense Percent (NNEP)
3.18% 1.61% -2.52% -0.76% 0.28% 1.29% 0.70% 0.69% 0.14% 0.48%
Cost of Revenue to Revenue
19.80% 21.09% 20.02% 18.94% 17.35% 15.90% 16.72% 16.91% 16.90% 17.31%
SG&A Expenses to Revenue
9.55% 9.36% 10.18% 10.51% 10.99% 9.40% 7.42% 7.51% 6.94% 7.06%
R&D to Revenue
17.40% 19.21% 20.16% 19.69% 18.77% 18.20% 16.94% 16.76% 16.75% 15.45%
Operating Expenses to Revenue
56.81% 62.11% 65.00% 65.92% 65.96% 60.98% 55.94% 56.10% 55.66% 53.89%
Earnings before Interest and Taxes (EBIT)
695 486 385 387 396 541 604 576 550 561
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
802 599 501 502 492 610 663 637 607 614
Valuation Ratios
- - - - - - - - - -
Price to Book Value (P/BV)
4.10 3.41 3.49 5.08 3.36 4.79 9.43 6.23 6.96 6.24
Price to Tangible Book Value (P/TBV)
15.71 18.68 41.11 83.45 20.12 12.13 16.63 11.38 13.11 10.81
Price to Revenue (P/Rev)
4.56 3.40 3.20 4.61 3.19 3.77 5.61 3.67 4.14 4.28
Price to Earnings (P/E)
22.64 24.20 26.76 36.19 24.43 19.74 26.73 18.21 22.55 22.53
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
4.42% 4.13% 3.74% 2.76% 4.09% 5.07% 3.74% 5.49% 4.43% 4.44%
Enterprise Value to Invested Capital (EV/IC)
5.74 4.39 4.20 6.71 5.04 16.51 0.00 0.00 267.74 48.71
Enterprise Value to Revenue (EV/Rev)
4.17 3.11 3.00 4.35 2.80 3.17 4.94 3.04 3.56 3.67
Enterprise Value to EBITDA (EV/EBITDA)
14.64 14.61 16.12 22.52 13.38 11.67 16.10 9.99 11.69 11.48
Enterprise Value to EBIT (EV/EBIT)
16.90 18.00 20.96 29.24 16.61 13.14 17.69 11.05 12.90 12.56
Enterprise Value to NOPAT (EV/NOPAT)
21.89 22.78 23.93 33.54 21.65 17.36 24.05 15.42 19.48 19.61
Enterprise Value to Operating Cash Flow (EV/OCF)
14.83 13.39 18.25 17.54 9.96 9.51 14.03 8.59 9.97 10.30
Enterprise Value to Free Cash Flow (EV/FCFF)
24.36 27.61 81.76 0.00 0.00 0.00 19.89 12.44 14.70 15.47
Leverage & Solvency
- - - - - - - - - -
Debt to Equity
0.00 0.00 0.14 0.16 0.17 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity
0.00 0.00 0.00 0.15 0.17 0.00 0.00 0.00 0.00 0.00
Financial Leverage
-0.32 -0.26 -0.25 -0.35 -0.56 -0.91 -1.09 -1.02 -0.93 -0.86
Leverage Ratio
1.83 2.00 2.13 2.11 2.02 1.97 2.02 1.98 1.85 1.67
Compound Leverage Factor
1.83 2.00 2.13 2.11 2.02 1.97 2.02 1.98 1.85 1.67
Debt to Total Capital
0.00% 0.00% 12.41% 13.52% 14.82% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital
0.00% 0.00% 12.41% 0.71% 0.74% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 12.82% 14.08% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
100.00% 100.00% 87.59% 86.48% 85.18% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA
0.00 0.00 0.70 0.73 0.79 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA
0.00 0.00 -1.09 -1.34 -1.88 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.70 0.75 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT
0.00 0.00 1.04 1.09 1.28 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT
0.00 0.00 -1.61 -2.00 -3.04 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT
0.00 0.00 0.00 1.04 1.21 0.00 0.00 0.00 0.00 0.00
Altman Z-Score
4.93 4.02 3.25 4.17 3.34 5.12 8.01 6.22 7.02 7.61
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - -
Current Ratio
1.42 1.26 1.04 1.16 1.39 1.37 1.49 1.50 1.53 1.57
Quick Ratio
0.98 0.85 0.74 0.90 1.17 1.17 1.40 1.40 1.36 1.40
Cash Flow Metrics
- - - - - - - - - -
Free Cash Flow to Firm (FCFF)
482 317 99 -41 -573 -186 537 511 482 456
Operating Cash Flow to CapEx
2,605.61% 1,205.91% 1,316.41% 2,104.98% 1,102.60% 722.26% 1,450.62% 1,913.81% 1,120.74% 1,135.09%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - -
Asset Turnover
0.52 0.53 0.52 0.54 0.58 0.75 0.85 0.87 0.86 0.85
Accounts Receivable Turnover
6.67 6.08 6.65 8.18 7.61 7.26 7.36 7.46 7.29 7.36
Inventory Turnover
9.94 11.38 11.94 19.74 13.09 10.98 11.97 11.07 9.95 11.42
Fixed Asset Turnover
17.53 16.62 15.00 12.39 10.39 12.17 16.16 17.02 18.21 23.60
Accounts Payable Turnover
8.50 6.72 6.16 7.79 6.42 5.92 6.66 8.33 7.94 7.03
Days Sales Outstanding (DSO)
54.69 60.00 54.87 44.63 47.99 50.25 49.59 48.91 50.09 49.59
Days Inventory Outstanding (DIO)
36.74 32.06 30.58 18.49 27.87 33.25 30.50 32.98 36.68 31.96
Days Payable Outstanding (DPO)
42.94 54.29 59.28 46.84 56.87 61.61 54.79 43.82 45.97 51.95
Cash Conversion Cycle (CCC)
48.48 37.77 26.17 16.28 19.00 21.88 25.30 38.07 40.80 29.60
Capital & Investment Metrics
- - - - - - - - - -
Invested Capital
2,046 1,992 1,925 1,686 1,308 431 -165 -72 26 145
Invested Capital Turnover
1.39 1.44 1.49 1.74 2.70 16.88 -18.21 -91.18 23.30 9.95
Increase / (Decrease) in Invested Capital
54 67 239 378 877 596 -93 -99 -118 -96
Enterprise Value (EV)
11,751 8,748 8,076 11,315 6,586 7,113 10,678 6,359 7,093 7,050
Market Capitalization
12,834 9,557 8,620 11,989 7,510 8,443 12,128 7,661 8,252 8,222
Book Value per Share
$53.69 $47.22 $41.45 $39.13 $36.49 $29.29 $21.14 $19.35 $17.90 $18.54
Tangible Book Value per Share
$14.02 $8.63 $3.52 $2.38 $6.10 $11.58 $12.00 $10.60 $9.51 $10.71
Total Capital
3,129 2,800 2,819 2,729 2,621 1,761 1,285 1,229 1,185 1,317
Total Debt
0.00 0.00 350 369 388 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt
0.00 0.00 0.00 350 369 0.00 0.00 0.00 0.00 0.00
Net Debt
-1,083 -808 -544 -674 -925 -1,331 -1,451 -1,302 -1,159 -1,172
Capital Expenditures (CapEx)
30 54 34 31 60 104 52 39 63 60
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-455 -427 -463 -672 -685 -566 -576 -545 -438 -341
Debt-free Net Working Capital (DFNWC)
620 376 422 239 524 406 463 472 445 433
Net Working Capital (NWC)
620 376 72 220 505 406 463 472 445 433
Net Nonoperating Expense (NNE)
-30 -11 15 6.07 -3.20 -18 -9.66 -8.45 -1.67 -5.49
Net Nonoperating Obligations (NNO)
-1,083 -808 -544 -674 -925 -1,331 -1,451 -1,302 -1,159 -1,172
Total Depreciation and Amortization (D&A)
107 113 116 115 96 69 59 61 57 53
Debt-free, Cash-free Net Working Capital to Revenue
-16.15% -15.19% -17.16% -25.80% -29.16% -25.25% -26.66% -26.09% -21.95% -17.78%
Debt-free Net Working Capital to Revenue
22.01% 13.37% 15.66% 9.17% 22.31% 18.11% 21.43% 22.57% 22.28% 22.56%
Net Working Capital to Revenue
22.01% 13.37% 2.68% 8.43% 21.49% 18.11% 21.43% 22.57% 22.28% 22.56%
Earnings Adjustments
- - - - - - - - - -
Adjusted Basic Earnings per Share
$9.65 $6.59 $5.34 $5.46 $0.00 $7.12 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic Shares Outstanding
58.72M 59.91M 60.27M 60.71M 0.00 60.04M 0.00 0.00 0.00 0.00
Adjusted Diluted Earnings per Share
$9.55 $6.55 $5.27 $5.34 $0.00 $7.08 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Diluted Shares Outstanding
59.36M 60.27M 61.10M 62.06M 0.00 60.46M 0.00 0.00 0.00 0.00
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $7.12 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
58.61M 59.71M 60.37M 61.23M 0.00 60.79M 0.00 0.00 0.00 0.00
Normalized Net Operating Profit after Tax (NOPAT)
544 437 344 337 310 410 458 422 370 360
Normalized NOPAT Margin
19.31% 15.54% 12.77% 12.96% 13.20% 18.28% 21.18% 20.19% 18.56% 18.73%
Pre Tax Income Margin
24.70% 17.28% 14.30% 14.86% 16.86% 24.13% 27.93% 27.54% 27.56% 29.24%
Debt Service Ratios
- - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
88.32% 88.63% 155.21% 150.95% 32.53% 47.00% 132.27% 142.62% 191.37% 166.26%

Quarterly Metrics And Ratios for F5

This table displays calculated financial ratios and metrics derived from F5's official financial filings.

Metric Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Growth Metrics
- - - - - - - - - - -
Revenue Growth
7.30% 10.67% 5.62% -1.02% -3.10% -1.11% 0.99% 4.17% 10.87% 1.93% 2.64%
EBITDA Growth
11.34% 13.77% 10.81% 47.16% 27.79% 65.06% 61.00% 3.83% 33.13% -13.10% -17.55%
EBIT Growth
17.31% 19.87% 16.41% 61.20% 34.15% 81.83% 75.32% 5.16% 49.61% -14.15% -19.26%
NOPAT Growth
18.33% 25.09% 3.82% 58.19% 43.79% 89.59% 55.12% -1.78% 37.51% -27.97% -14.95%
Net Income Growth
22.27% 20.28% 8.65% 61.93% 46.15% 91.13% 70.28% 7.18% 44.81% -22.61% -19.30%
EPS Growth
24.00% 21.55% 10.28% 64.86% 49.25% 93.33% 72.11% 8.03% 45.65% -20.53% -16.95%
Operating Cash Flow Growth
15.77% 22.66% 29.88% -3.69% 57.28% 4.88% 22.96% 131.16% 11.39% 74.44% -21.67%
Free Cash Flow Firm Growth
106.63% 624.07% 22.55% -34.09% 208.88% 233.30% 157.75% 135.37% 1.74% 97.04% 46.22%
Invested Capital Growth
0.93% 2.20% 2.73% 5.45% 2.94% 5.96% 3.49% 2.13% 7.15% 4.43% 14.16%
Revenue Q/Q Growth
-4.61% 2.65% 7.36% 2.08% -1.62% -2.03% 0.62% -0.08% 0.40% 0.05% 3.79%
EBITDA Q/Q Growth
-16.42% 2.33% 14.14% 14.05% -14.59% -0.34% 51.58% -0.96% 10.33% -2.79% -2.25%
EBIT Q/Q Growth
-18.10% 2.72% 18.58% 17.60% -16.32% -0.24% 64.21% -2.13% 13.42% -3.81% -1.51%
NOPAT Q/Q Growth
-17.28% 5.25% 13.32% 19.95% -12.56% -12.65% 72.66% 9.03% 15.30% -28.54% 9.34%
Net Income Q/Q Growth
-12.57% 0.70% 14.73% 21.05% -13.99% -9.04% 70.98% 9.26% 12.48% -18.96% 7.62%
EPS Q/Q Growth
-12.06% 1.08% 14.34% 22.00% -13.79% -8.30% 70.95% 10.45% 11.67% -18.37% 7.30%
Operating Cash Flow Q/Q Growth
26.54% -17.74% 55.07% -28.28% 34.07% -12.90% 14.99% 17.12% -10.60% 2.12% 116.18%
Free Cash Flow Firm Q/Q Growth
-1.93% 17.63% 234.86% -46.51% 243.66% -80.09% 80.09% 188.35% -320.74% 91.37% -10.31%
Invested Capital Q/Q Growth
-1.52% 1.34% -1.05% 2.19% -0.27% 1.86% 1.57% -0.23% 2.65% -0.51% 0.24%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
80.72% 81.67% 80.75% 80.38% 79.29% 80.31% 80.06% 79.84% 77.86% 77.87% 78.94%
EBITDA Margin
26.49% 30.23% 30.33% 28.53% 25.53% 29.41% 28.91% 19.19% 19.36% 17.62% 18.13%
Operating Margin
21.73% 26.76% 25.58% 23.45% 20.54% 23.75% 24.29% 14.74% 15.08% 13.02% 15.36%
EBIT Margin
23.42% 27.27% 27.26% 24.68% 21.42% 25.18% 24.73% 15.15% 15.47% 13.69% 14.24%
Profit (Net Income) Margin
19.91% 21.72% 22.14% 20.72% 17.47% 19.98% 21.52% 12.66% 11.58% 10.34% 12.76%
Tax Burden Percent
85.01% 79.62% 81.22% 83.95% 81.56% 79.35% 87.02% 83.57% 74.86% 75.49% 89.60%
Interest Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate
14.99% 20.38% 18.78% 16.05% 18.44% 20.65% 12.98% 16.43% 25.14% 24.51% 10.40%
Return on Invested Capital (ROIC)
26.72% 30.01% 28.98% 27.13% 23.38% 26.82% 30.37% 17.81% 16.51% 14.21% 20.55%
ROIC Less NNEP Spread (ROIC-NNEP)
25.76% 29.70% 27.91% 26.26% 22.80% 25.77% 29.97% 17.37% 16.20% 13.64% 21.70%
Return on Net Nonoperating Assets (RNNOA)
-9.00% -9.71% -8.90% -7.60% -6.73% -7.10% -7.69% -3.83% -4.18% -3.39% -5.48%
Return on Equity (ROE)
17.72% 20.30% 20.08% 19.54% 16.65% 19.72% 22.67% 13.98% 12.33% 10.82% 15.08%
Cash Return on Invested Capital (CROIC)
28.13% 25.59% 23.89% 21.05% 21.19% 16.82% 16.18% 14.90% 10.55% 12.22% 5.47%
Operating Return on Assets (OROA)
12.19% 14.01% 14.13% 13.01% 11.24% 13.54% 13.22% 8.39% 8.34% 7.29% 7.48%
Return on Assets (ROA)
10.36% 11.16% 11.48% 10.92% 9.17% 10.74% 11.50% 7.01% 6.25% 5.51% 6.70%
Return on Common Equity (ROCE)
17.72% 20.30% 20.08% 19.54% 16.65% 19.72% 22.67% 13.98% 12.33% 10.82% 15.08%
Return on Equity Simple (ROE_SIMPLE)
18.75% 18.38% 0.00% 18.39% 17.00% 16.11% 0.00% 12.50% 11.97% 11.66% 0.00%
Net Operating Profit after Tax (NOPAT)
135 163 155 137 114 131 149 87 79 69 96
NOPAT Margin
18.47% 21.30% 20.78% 19.69% 16.75% 18.85% 21.14% 12.32% 11.29% 9.83% 13.76%
Net Nonoperating Expense Percent (NNEP)
0.96% 0.32% 1.07% 0.87% 0.58% 1.05% 0.40% 0.44% 0.31% 0.57% -1.15%
Return On Investment Capital (ROIC_SIMPLE)
4.08% 5.05% - - - 4.56% - - - - -
Cost of Revenue to Revenue
19.28% 18.33% 19.25% 19.62% 20.71% 19.69% 19.94% 20.16% 22.14% 22.13% 21.07%
SG&A Expenses to Revenue
10.48% 9.53% 9.51% 9.48% 9.86% 9.34% 8.71% 9.22% 9.53% 9.99% 9.93%
R&D to Revenue
18.68% 17.03% 16.60% 17.88% 17.94% 17.26% 18.08% 18.33% 20.10% 20.32% 19.79%
Operating Expenses to Revenue
58.99% 54.91% 55.17% 56.94% 58.75% 56.55% 55.77% 65.10% 62.78% 64.84% 63.57%
Earnings before Interest and Taxes (EBIT)
171 209 204 172 146 174 175 106 109 96 100
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
194 232 226 198 174 204 204 135 136 123 127
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
4.63 4.56 4.10 3.35 3.80 3.71 3.41 3.33 3.21 3.35 3.49
Price to Tangible Book Value (P/TBV)
15.44 15.96 15.71 14.45 17.96 18.55 18.68 23.98 20.05 26.82 41.11
Price to Revenue (P/Rev)
5.22 5.10 4.56 3.64 4.01 3.78 3.40 3.15 3.15 3.20 3.20
Price to Earnings (P/E)
24.71 24.78 22.64 18.23 22.36 23.03 24.20 26.63 26.85 28.78 26.76
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
4.05% 4.04% 4.42% 5.48% 4.47% 4.34% 4.13% 3.76% 3.72% 3.47% 3.74%
Enterprise Value to Invested Capital (EV/IC)
6.89 6.55 5.74 4.43 5.06 4.82 4.39 4.15 4.07 4.18 4.20
Enterprise Value to Revenue (EV/Rev)
4.79 4.70 4.17 3.30 3.68 3.49 3.11 2.90 2.88 2.95 3.00
Enterprise Value to EBITDA (EV/EBITDA)
16.56 16.35 14.64 11.73 14.28 14.41 14.61 15.63 15.49 16.58 16.12
Enterprise Value to EBIT (EV/EBIT)
18.64 18.60 16.90 13.73 17.02 17.33 18.00 19.83 19.72 21.63 20.96
Enterprise Value to NOPAT (EV/NOPAT)
23.84 23.84 21.89 17.24 21.31 21.95 22.78 24.68 24.13 25.78 23.93
Enterprise Value to Operating Cash Flow (EV/OCF)
16.28 16.36 14.83 12.44 13.80 14.80 13.39 13.18 15.26 15.68 18.25
Enterprise Value to Free Cash Flow (EV/FCFF)
24.62 25.87 24.36 21.58 24.23 29.50 27.61 28.17 39.91 34.91 81.76
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.14
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage
-0.35 -0.33 -0.32 -0.29 -0.30 -0.28 -0.26 -0.22 -0.26 -0.25 -0.25
Leverage Ratio
1.81 1.85 1.83 1.86 1.87 1.92 2.00 2.04 2.01 2.04 2.13
Compound Leverage Factor
1.81 1.85 1.83 1.86 1.87 1.92 2.00 2.04 2.01 2.04 2.13
Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 12.41%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 12.41%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 87.59%
Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.70
Net Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -1.09
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.04
Net Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -1.61
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score
5.09 4.85 4.64 4.03 4.20 4.04 3.82 3.55 3.46 3.40 3.07
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.53 1.48 1.42 1.36 1.30 1.29 1.26 1.15 1.20 1.12 1.04
Quick Ratio
1.08 1.03 0.98 0.93 0.86 0.88 0.85 0.76 0.81 0.75 0.74
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
116 119 101 30 56 16 82 46 -52 -12 -142
Operating Cash Flow to CapEx
2,443.08% 2,511.85% 4,067.74% 2,717.71% 2,344.12% 1,827.12% 1,233.92% 1,099.70% 1,318.39% 1,202.92% 1,814.45%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.52 0.51 0.52 0.53 0.52 0.54 0.53 0.55 0.54 0.53 0.52
Accounts Receivable Turnover
7.66 5.79 6.67 6.46 6.37 5.62 6.08 6.27 6.17 5.99 6.65
Inventory Turnover
8.16 10.30 9.94 8.90 9.30 12.09 11.38 13.35 14.98 13.99 11.94
Fixed Asset Turnover
18.95 18.23 17.53 17.07 16.80 16.76 16.62 16.35 15.94 15.35 15.00
Accounts Payable Turnover
11.09 9.88 8.50 9.32 8.78 8.72 6.72 8.64 8.47 8.61 6.16
Days Sales Outstanding (DSO)
47.67 63.03 54.69 56.50 57.30 64.95 60.00 58.22 59.11 60.94 54.87
Days Inventory Outstanding (DIO)
44.73 35.44 36.74 40.99 39.26 30.18 32.06 27.35 24.37 26.09 30.58
Days Payable Outstanding (DPO)
32.92 36.94 42.94 39.18 41.59 41.87 54.29 42.27 43.11 42.40 59.28
Cash Conversion Cycle (CCC)
59.48 61.53 48.48 58.31 54.97 53.26 37.77 43.31 40.38 44.62 26.17
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
2,042 2,074 2,046 2,068 2,023 2,029 1,992 1,961 1,966 1,915 1,925
Invested Capital Turnover
1.45 1.41 1.39 1.38 1.40 1.42 1.44 1.45 1.46 1.45 1.49
Increase / (Decrease) in Invested Capital
19 45 54 107 58 114 67 41 131 81 239
Enterprise Value (EV)
14,079 13,578 11,751 9,152 10,239 9,783 8,748 8,148 7,999 7,996 8,076
Market Capitalization
15,351 14,740 12,834 10,095 11,149 10,615 9,557 8,844 8,759 8,663 8,620
Book Value per Share
$57.48 $55.20 $53.69 $51.37 $49.88 $48.39 $47.22 $43.95 $45.33 $42.78 $41.45
Tangible Book Value per Share
$17.24 $15.75 $14.02 $11.92 $10.56 $9.68 $8.63 $6.10 $7.27 $5.35 $3.52
Total Capital
3,314 3,236 3,129 3,011 2,933 2,861 2,800 2,658 2,726 2,582 2,819
Total Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 350
Total Long-Term Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt
-1,272 -1,162 -1,083 -943 -910 -832 -808 -696 -760 -668 -544
Capital Expenditures (CapEx)
11 8.07 6.06 5.85 9.46 9.05 15 15 11 13 8.51
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-447 -397 -455 -405 -454 -389 -427 -466 -456 -479 -463
Debt-free Net Working Capital (DFNWC)
812 754 620 531 449 437 376 224 300 181 422
Net Working Capital (NWC)
812 754 620 531 449 437 376 224 300 181 72
Net Nonoperating Expense (NNE)
-10 -3.15 -10 -7.16 -4.87 -7.84 -2.68 -2.42 -2.05 -3.55 7.00
Net Nonoperating Obligations (NNO)
-1,272 -1,162 -1,083 -943 -910 -832 -808 -696 -760 -668 -544
Total Depreciation and Amortization (D&A)
22 23 23 27 28 29 30 28 27 27 27
Debt-free, Cash-free Net Working Capital to Revenue
-15.21% -13.72% -16.15% -14.59% -16.32% -13.85% -15.19% -16.62% -16.40% -17.67% -17.16%
Debt-free Net Working Capital to Revenue
27.62% 26.10% 22.01% 19.11% 16.13% 15.59% 13.37% 7.99% 10.78% 6.68% 15.66%
Net Working Capital to Revenue
27.62% 26.10% 22.01% 19.11% 16.13% 15.59% 13.37% 7.99% 10.78% 6.68% 2.68%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$2.51 $2.85 $2.83 $2.46 $2.02 $2.34 $2.56 $1.48 $1.35 $1.20 $1.49
Adjusted Weighted Average Basic Shares Outstanding
57.89M 58.31M 58.72M 58.58M 58.79M 59.12M 59.91M 59.98M 60.33M 60.10M 60.27M
Adjusted Diluted Earnings per Share
$2.48 $2.82 $2.79 $2.44 $2.00 $2.32 $2.53 $1.48 $1.34 $1.20 $1.47
Adjusted Weighted Average Diluted Shares Outstanding
58.76M 59.06M 59.36M 59.15M 59.58M 59.65M 60.27M 60.31M 60.69M 60.39M 61.10M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
57.43M 57.65M 58.61M 58.28M 58.61M 58.81M 59.71M 59.31M 60.47M 60.12M 60.37M
Normalized Net Operating Profit after Tax (NOPAT)
135 172 155 137 114 137 149 134 79 75 96
Normalized NOPAT Margin
18.47% 22.48% 20.78% 19.70% 16.76% 19.82% 21.14% 19.06% 11.29% 10.77% 13.76%
Pre Tax Income Margin
23.42% 27.27% 27.26% 24.68% 21.42% 25.18% 24.73% 15.15% 15.47% 13.69% 14.24%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
80.89% 79.95% 88.32% 83.10% 112.35% 99.81% 88.63% 87.32% 88.90% 137.88% 155.21%

Frequently Asked Questions About F5's Financials

When does F5's fiscal year end?

According to the most recent income statement we have on file, F5's financial year ends in September. Their financial year 2024 ended on September 30, 2024.

How has F5's net income changed over the last 9 years?
The last 5 years of F5's net income performance:
  • 2020: $307.44 million
  • 2021: $331.24 million
  • 2022: $322.16 million
  • 2023: $394.95 million
  • 2024: $566.78 million
Find out what analysts predict for F5 in the coming months.
What is F5's operating income?
F5's total operating income in 2024 was $658.59 million, based on the following breakdown:
  • Total Gross Profit: $2.26 billion
  • Total Operating Expenses: $1.60 billion
How has F5 revenue changed over the last 9 years?

Over the last 9 years, F5's total revenue changed from $1.92 billion in 2015 to $2.82 billion in 2024, a change of 46.7%.

How much debt does F5 have?

F5's total liabilities were at $2.48 billion at the end of 2024, a 1.5% increase from 2023, and a 149.5% increase since 2015.

How much cash does F5 have?

In the past 9 years, F5's cash and equivalents has ranged from $390.46 million in 2015 to $1.07 billion in 2024, and is currently $1.07 billion as of their latest financial filing in 2024.

How has F5's book value per share changed over the last 9 years?

Over the last 9 years, F5's book value per share changed from 18.54 in 2015 to 53.69 in 2024, a change of 189.5%.



This page (NASDAQ:FFIV) was last updated on 5/28/2025 by MarketBeat.com Staff
From Our Partners